|View printer-friendly version|
Portola Pharmaceuticals to Participate in Two Upcoming Investor Conferences
William Blair39th Annual Growth Stock Conferenceon Thursday, June 6, 2019, at 3:20 p.m. Central Timein Chicago, IL.
Goldman Sachs40th Annual Global Healthcare Conference on Tuesday, June 11, 2019, at 2:40 p.m. Pacific Timein Rancho Palos Verdes, CA.
Both presentations will be webcast live and available for replay in the Investor Relations section of the Portola website (www.portola.com).
Portola Pharmaceuticals is a global, commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics that could significantly advance the fields of thrombosis and other hematologic conditions. The Company’s first two commercialized products are Andexxa® [coagulation factor Xa (recombinant), inactivated-zhzo], marketed in
|Investor Contact:||Media Contact:|
|Cara Miller||Pure Communications|
Source: Portola Pharmaceuticals, Inc.